Spencer E. Brightman
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- Immune Cell Function and Interaction
- Microbiology top 10%
- Bacterial Infections and Vaccines
Papers in
- Immunology 10
- Immunotherapy and Immune Responses 6
- Immune Response and Inflammation 4
- Oncology 6
- Cancer Immunotherapy and Biomarkers 5
- CAR-T cell therapy research 5
- Co-authors
- Stephen P. Schoenberger (6 shared papers)Bruce R. Zetter (1 shared paper)Martin S. Naradikian (5 shared papers)Aaron M. Miller (4 shared papers)Ofer Levy (7 shared papers)David J. Dowling (7 shared papers)Carlo Pietrasanta (3 shared papers)Ilana Bergelson (3 shared papers)
- Journals
- Frontiers in Immunology (2 papers)Vaccine (1 paper)Journal of Leukocyte Biology (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)Nature Immunology (1 paper)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Spencer E. Brightman
14 papers receiving 405 citations
Peers
Comparison fields: 5 of 65
- Immunology 225
- Microbiology 39
- Oncology 85
- Immunology and Allergy 17
- Infectious Diseases 51
Countries citing papers authored by Spencer E. Brightman
This map shows the geographic impact of Spencer E. Brightman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Spencer E. Brightman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Spencer E. Brightman more than expected).
Fields of papers citing papers by Spencer E. Brightman
This network shows the impact of papers produced by Spencer E. Brightman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Spencer E. Brightman. The network helps show where Spencer E. Brightman may publish in the future.
Co-authors
The 25 scholars most cited alongside Spencer E. Brightman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 109 | |
| 2 | 2020 | 45 | |
| 3 | 2023 | 44 | |
| 4 | 2023 | 39 | |
| 5 | 1990 | 37 | |
| 6 | 2017 | 32 | |
| 7 | 2016 | 29 | |
| 8 | 2016 | 24 | |
| 9 | 2022 | 16 | |
| 10 | 2018 | 16 | |
| 11 | 2024 | 9 | |
| 12 | 2022 | 8 | |
| 13 | 2025 | 1 | |
| 14 | 2018 | 1 |
About Spencer E. Brightman
Spencer E. Brightman is a scholar working on Immunology, Oncology, Epidemiology, Microbiology and Immunology and Allergy, having authored 14 papers that have together received 410 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), CAR-T cell therapy research (5 papers), Influenza Virus Research Studies (4 papers), Bacterial Infections and Vaccines (4 papers), Immune Response and Inflammation (4 papers), Pneumonia and Respiratory Infections (3 papers) and Cell Adhesion Molecules Research (1 paper). The work is most often cited by research in Immunology (225 citations), Microbiology (39 citations), Oncology (85 citations), Immunology and Allergy (17 citations) and Infectious Diseases (51 citations). Spencer E. Brightman has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Stephen P. Schoenberger, Bruce R. Zetter, Martin S. Naradikian, Aaron M. Miller, Ofer Levy, David J. Dowling, Carlo Pietrasanta, Ilana Bergelson, Simon D. van Haren and Ezra E.W. Cohen. Their work appears in journals such as Frontiers in Immunology, Vaccine, Journal of Leukocyte Biology, Journal for ImmunoTherapy of Cancer and Nature Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.